Cargando…

Mass spectrometry-based intraoperative tumor diagnostics

In surgical oncology, decisions regarding the amount of tissue to be removed can have important consequences: the decision between preserving sufficient healthy tissue and eliminating all tumor cells is one to be made intraoperatively. This review discusses the latest technical innovations for a mor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hänel, Lorena, Kwiatkowski, Marcel, Heikaus, Laura, Schlüter, Hartmut
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Science Ltd 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426168/ https://www.ncbi.nlm.nih.gov/pubmed/30906569 http://dx.doi.org/10.4155/fsoa-2018-0087

Ejemplares similares

Mass spectrometry-based intraoperative tumor diagnostics: a letter in reply
por: Fournier, Isabelle, et al.
Publicado: (2019)

Differential Proteome Analysis of Human Neuroblastoma Xenograft Primary Tumors and Matched Spontaneous Distant Metastases
por: Hänel, Lorena, et al.
Publicado: (2018)

Rapid MALDI-TOF Mass Spectrometry Strain Typing during a Large Outbreak of Shiga-Toxigenic Escherichia coli
por: Christner, Martin, et al.
Publicado: (2014)

Application of Displacement Chromatography to Online Two-Dimensional Liquid Chromatography Coupled to Tandem Mass Spectrometry Improves Peptide Separation Efficiency and Detectability for the Analysis of Complex Proteomes
por: Kwiatkowski, Marcel, et al.
Publicado: (2018)

Mass spectrometry for monitoring protease reactions
por: Schlüter, H., et al.
Publicado: (2008)

Prospective on Imaging Mass Spectrometry in Clinical Diagnostics
por: Moore, Jessica L., et al.
Publicado: (2023)

Statistical quality assessment and outlier detection for liquid chromatography-mass spectrometry experiments
por: Schulz-Trieglaff, Ole, et al.
Publicado: (2009)

Host Cell Proteins in Biologics Manufacturing: The Good, the Bad, and the Ugly
por: Kornecki, Martin, et al.
Publicado: (2017)

An Integrated Strategy Reveals Complex Glycosylation of Erythropoietin Using Mass Spectrometry
por: Guan, Yudong, et al.
Publicado: (2021)

Inferring Proteolytic Processes from Mass Spectrometry Time Series Data Using Degradation Graphs
por: Aiche, Stephan, et al.
Publicado: (2012)

Correction to An Integrated Strategy Reveals Complex Glycosylation of Erythropoietin Using Mass Spectrometry
por: Guan, Yudong, et al.
Publicado: (2022)

Empowering Clinical Diagnostics with Mass Spectrometry
por: Banerjee, Shibdas
Publicado: (2020)

Native mass spectrometry provides sufficient ion flux for XFEL single-particle imaging
por: Uetrecht, Charlotte, et al.
Publicado: (2019)

Lipidome Analysis of Oropharyngeal Tumor Tissues Using Nanosecond Infrared Laser (NIRL) Tissue Sampling and Subsequent Mass Spectrometry
por: Stadlhofer, Rupert, et al.
Publicado: (2023)

Interim clinical trial analysis of intraoperative mass spectrometry for breast cancer surgery
por: Basu, Sankha S., et al.
Publicado: (2021)

Identification of Diagnostic Metabolic Signatures in Thyroid Tumors Using Mass Spectrometry Imaging
por: Mao, Xinxin, et al.
Publicado: (2023)

Contributions of mass spectrometry-based proteomics to defining cellular mechanisms and diagnostic markers for systemic lupus erythematosus
por: Korte, Erik A, et al.
Publicado: (2012)

Mass Spectrometry-Based Proteomics in Molecular Diagnostics: Discovery of Cancer Biomarkers Using Tissue Culture
por: Paul, Debasish, et al.
Publicado: (2013)

Proteomic Advances in Glial Tumors through Mass Spectrometry Approaches
por: Pirlog, Radu, et al.
Publicado: (2019)

Current perspectives on mass spectrometry-based immunopeptidomics: the computational angle to tumor antigen discovery
por: Zhang, Bing, et al.
Publicado: (2023)

Mass spectrometry–based proteomics in cell biology
por: Walther, Tobias C., et al.
Publicado: (2010)

Functional phosphoproteomic mass spectrometry-based approaches
por: López, Elena, et al.
Publicado: (2012)

Mass Spectrometry-Based Glycoproteomics and Prostate Cancer
por: Gabriele, Caterina, et al.
Publicado: (2021)

Mass Spectrometry Imaging
por: Shimma, Shuichi
Publicado: (2022)

Structural and In Vitro Functional Comparability Analysis of Altebrel™, a Proposed Etanercept Biosimilar: Focus on Primary Sequence and Glycosylation
por: Fazel, Ramin, et al.
Publicado: (2019)

Serum Biomarkers Identification by Mass Spectrometry in High-Mortality Tumors
por: Tessitore, Alessandra, et al.
Publicado: (2013)

Web Resources for Mass Spectrometry-based Proteomics
por: Chen, Tao, et al.
Publicado: (2015)

Advances in MALDI Mass Spectrometry in Clinical Diagnostic Applications
por: Ng, Eddy W. Y., et al.
Publicado: (2013)

IVDR and diagnostic application of mass spectrometry in the European Union
por: Vogeser, Michael
Publicado: (2021)

Liquid chromatography–tandem mass spectrometry for clinical diagnostics
por: Thomas, Stefani N., et al.
Publicado: (2022)

Emerging Technologies in Mass Spectrometry-Based DNA Adductomics
por: Guo, Jingshu, et al.
Publicado: (2019)

Oxidative protein labeling in mass-spectrometry-based proteomics
por: Roeser, Julien, et al.
Publicado: (2010)

Mass Spectrometry Based Lipidomics: An Overview of Technological Platforms
por: Köfeler, Harald C., et al.
Publicado: (2012)

Mass Spectrometry-Based N-Glycomics of Colorectal Cancer
por: Sethi, Manveen K., et al.
Publicado: (2015)

Advances in mass spectrometry-based clinical biomarker discovery
por: Crutchfield, Christopher A., et al.
Publicado: (2016)

Native Mass Spectrometry in Fragment-Based Drug Discovery
por: Pedro, Liliana, et al.
Publicado: (2016)

Machine Learning Applications for Mass Spectrometry-Based Metabolomics
por: Liebal, Ulf W., et al.
Publicado: (2020)

Mass Spectrometry-Based Identification of MHC-Associated Peptides
por: Kote, Sachin, et al.
Publicado: (2020)

Mass Spectrometry-Based Discovery of in vitro Kinome Substrates
por: Sugiyama, Naoyuki
Publicado: (2020)

Progress of Mass Spectrometry-Based Lipidomics in the Dairy Field
por: Ren, Wei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v7a3vaf3tspvstj4s8ktuui4ig